Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015

Background Proton pump inhibitors (PPIs) are one of the most commonly prescribed pharmacological groups. Their high prevalence and duration of use are of important health concern due to the risk they can cause to patients. Despite these risks, their use remains particularly high, especially in the e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC public health Jg. 22; H. 1; S. 818 - 8
Hauptverfasser:	Torres-Bondia, F., de Batlle, J., Galván, L., Buti, M., Barbé, F., Piñol-Ripoll, G.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 24.04.2022 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Access control Age Aged Alzheimer's disease Biostatistics Cognitive ability Consumption Dementia Dispensing Distribution Dosage and administration Drug dosages Drug safety Drug stores Drug utilization Environmental Health Epidemiology Esomeprazole Evolution Female Humans Hypertension Inhibitors Long term Male Medicine Medicine & Public Health Middle Aged Mutual insurance companies Omeprazole Pharmacy Population Prescribing trends Prescription drugs Primary care Proton pump inhibitors Proton Pump Inhibitors - therapeutic use Protons Public Health Risk Standard deviation Trends Ulcers Vaccine Women Womens health Spain Proton pump inhibitors Prescribing trends Long term Drug safety Drug utilization
ISSN:	1471-2458, 1471-2458
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!